US Stock MarketDetailed Quotes

BHC Bausch Health

Watchlist
  • 10.610
  • +0.120+1.14%
Close Mar 28 16:00 ET
  • 10.610
  • 0.0000.00%
Post 19:47 ET
3.88BMarket Cap-6549P/E (TTM)

About Bausch Health Company

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.

Company Profile

SymbolBHC
Company NameBausch Health
Listing Date12/12/1996
Founded2002
CEOMr. Thomas J. Appio
MarketNYSE
Employees20270
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2150 St. Elzéar Boulevard West
CityLaval
ProvinceQuébec
CountryCanada
Zip CodeH7L 4A8
Phone1-514-744-6792

Company Executives

  • Name
  • Position
  • Salary
  • Thomas J. Appio
  • Chief Executive Officer and Director
  • 13.17M
  • Sam A. Eldessouky
  • Executive Vice President and Chief Financial Officer of Bausch + Lomb
  • 6.15M
  • John S. Barresi
  • Interim Chief Financial Officer, Senior Vice President, Controller and Chief Accounting Officer
  • --
  • Christina M. Ackermann
  • Executive Vice President, General Counsel and President, Ophthalmic Pharmaceuticals of Bausch + Lomb
  • 4.74M
  • Seana Carson
  • Executive Vice President and General Counsel
  • 4.21M
  • John A. Paulson
  • Chairman of the Board
  • 701.74K
  • Robert N. Power
  • Independent Director
  • 399.15K
  • Dr. Richard C. Mulligan, PhD
  • Independent Director
  • 352.45K
  • Brett M. Icahn
  • Independent Director
  • 615.49K
  • Russel C. Robertson
  • Independent Director
  • 679.58K
  • Christian A. Garcia
  • Independent Director
  • --
  • Sarah B. Kavanagh
  • Independent Director
  • 698.89K
  • Thomas W. Ross, Sr
  • Independent Director
  • 752.30K
  • Dr. Amy B. Wechsler, M.D.
  • Independent Director
  • 377.50K
  • Frank D. Lee
  • Independent Director
  • --
  • Steven D. Miller
  • Independent Director
  • 370.69K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg